Synthesis, Characterization and Cytotoxicity of (η6-p-cymene)ruthenium(II) Complexes of α-Amino Acids

Exploration of the medical periodic table: towards new targets

(2013) Nicolas P. E. Barry et al.   CHEMICAL COMMUNICATIONS

Kinetic and mechanistic studies on reactions of diruthenium(ii,iii) with biologically relevant reducing agents

(2013) Rodrigo Luis Silva Ribeiro Santos et al.   DALTON TRANSACTIONS

Tuning the Hydrolytic Properties of Half-Sandwich-Type Organometallic Cations in Aqueous Solution

(2013) Linda Bíró et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Synthesis, characterization and in vitro anticancer activity of highly cytotoxic trithiolato diruthenium complexes of the type [(η6-p-MeC6H4iPr)2Ru2(μ2-SR1)2(μ2-SR2)]+ containing different thiolato bridges

(2013) Federico Giannini et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Highly cytotoxic diruthenium trithiolato complexes of the type [(η6-p-MeC6H4Pri)2Ru2(μ2-SR)3]+: synthesis, characterization, molecular structure and in vitro anticancer activity

(2013) Federico Giannini et al.   NEW JOURNAL OF CHEMISTRY

Enzyme inhibition by metal complexes: concepts, strategies and applications

(2013) Kelly J. Kilpin et al.   Chemical Science

Insights into the Mechanism of Action and Cellular Targets of Ruthenium Complexes from NMR Spectroscopy

(2012) Federico Giannini et al.   CHIMIA

The potential of organometallic complexes in medicinal chemistry

(2012) Gilles Gasser et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Next-Generation Anticancer Metallodrugs

(2012) Seiji Komeda et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Interaction of a ruthenium hexacationic prism with amino acids and biological ligands: ESI mass spectrometry and NMR characterisation of the reaction products

(2012) Lydia E. H. Paul et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential

(2012) Federico Giannini et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Reactions of a cytotoxic hexanuclear arene ruthenium assembly with biological ligands

(2012) Lydia E.H. Paul et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Interaction between [Ru(η6-p-cym)(H2O)3]2+ and dl-serine or dl-isoserine: The role of the side chain alcoholic OH group in metal ion binding

(2012) Linda Bíró et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Metal Complexes as DNA Intercalators

(2011) Hong-Ke Liu et al.   ACCOUNTS OF CHEMICAL RESEARCH

A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core

(2011) Bin Wu et al.   CHEMISTRY-A EUROPEAN JOURNAL

Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study

(2011) Linda Bíró et al.   DALTON TRANSACTIONS

Investigation of the Reactivity between a Ruthenium Hexacationic Prism and Biological Ligands

(2011) Lydia E. H. Paul et al.   INORGANIC CHEMISTRY

Efficient Oxidation of Cysteine and Glutathione Catalyzed by a Dinuclear Areneruthenium Trithiolato Anticancer Complex

(2011) Federico Giannini et al.   INORGANIC CHEMISTRY

Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?

(2011) Irina Buß et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Approaching tumour therapy beyond platinum drugs

(2011) A. Bergamo et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Ruthenium-based chemotherapeutics: are they ready for prime time?

(2010) Emmanuel S. Antonarakis et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A robust, sensitive, and versatile HMBC experiment for rapid structure elucidation by NMR: IMPACT-HMBC

(2010) Julien Furrer   CHEMICAL COMMUNICATIONS

Is the Reactivity of M(II)−Arene Complexes of 3-Hydroxy-2(1H)-pyridones to Biomolecules the Anticancer Activity Determining Parameter?

(2010) Muhammad Hanif et al.   INORGANIC CHEMISTRY

Organometallic Anticancer Compounds

(2010) Gilles Gasser et al.   JOURNAL OF MEDICINAL CHEMISTRY

Organometallic ruthenium-based antitumor compounds with novel modes of action

(2010) Wee Han Ang et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Areneruthenium complexes as anticancer agents

(2009) Georg Süss-Fink   DALTON TRANSACTIONS

Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs

(2009) Sabine H. van Rijt et al.   DRUG DISCOVERY TODAY

Elucidation of the Interactions of an Anticancer Ruthenium Complex in Clinical Trials with Biomolecules Utilizing Capillary Electrophoresis Hyphenated to Inductively Coupled Plasma-Mass Spectrometry. Short Communication

(2008) Michael Groessl et al.   CHEMISTRY & BIODIVERSITY

KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients

(2008) Christian G. Hartinger et al.   CHEMISTRY & BIODIVERSITY

Medicinal Organometallic Chemistry: Designing Metal Arene Complexes as Anticancer Agents

(2008) Anna F. A. Peacock et al.   Chemistry-An Asian Journal